Enodia Therapeutics Appoints Henrik Torp Nielsen as Chief Financial Officer
PRIVATEOct 29, 2026
Position
Chief Financial Officer
Company
Enodia Therapeutics
Henrik Torp Nielsen
ParisBiotechnologyTherapeutics
Description
Enodia Therapeutics has appointed Henrik Torp Nielsen as Chief Financial Officer. Mr. Nielsen brings nearly two decades of experience in biopharma finance and operations to lead the company's financial strategy as they advance their Sec61 platform.
Who to call at Enodia Therapeutics, and when
A new leader at Enodia Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Enodia Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Enodia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enodia Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Enodia Therapeutics
Location
Paris, Ile-de-France, France
About
Enodia Therapeutics is a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis. Their proprietary discovery platform utilizes machine learning to selectively modulate the SEC61 translocon, enabling intervention upstream of disease without compromising vital physiological functions. This approach aims to unlock previously undruggable secreted and membrane protein targets. The company focuses on treating high-unmet-need conditions using a tailored library of signal-peptide cell lines.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enodia Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ParisBiotechnologyTherapeutics